LATEST ALERTS
This ECigIntelligence market snapshot for New Zealand covers key indicators such as recent, present and predicted market size, an indication of regulation level and an overview of the top available brands
This market snapshot for New Zealand covers key indicators: recent, present and forecast market size; regulation level; an overview of the top available brands, form factors, retail distribution, prices and affordability
This interactive tracking tool presents online traffic changes in the vape retail sector across 32 countries, including analysis of total online traffic evolution per country, total regional online traffic by retailer type, and changes in domestic traffic.
This market snapshot for New Zealand covers key indicators: recent, present and forecast market size; regulation level; an overview of the top available brands, form factors, retail distribution, prices and affordability
This market snapshot for New Zealand covers key indicators: recent, present and forecast market size; regulation level; an overview of the top available brands, form factors, retail distribution, prices and affordability
With fewer smokers than in other countries, there is less scope for e-cigarettes to flourish in either country – but legal changes afoot in New Zealand reveal a more positive attitude to vaping than in Australia
The sale of e-cigarettes containing nicotine is banned in both Australia and New Zealand. Though there is a grassroots move to change this, both markets are currently led by online imports for personal use.
Market analysis • Market size • Consumption patterns • Pricing and spend • Sales, distribution and marketing • Brands • Regulatory analysis • Australia: national regulation • Australia: the Therapeutic Goods Administration • Australia: personal imports • Australia: state and territory regulation • Australia: taxation • Australia: the future of e-cig regulation • New Zealand: national regulation • New Zealand: medical regulation • New Zealand: regulatory forecast • Appendix 1: importation into Australia • Appendix 2: New Zealand Medicines Act 1981
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.
